AstraZeneca Expands Virginia Site with $4.5B Investment, Adding 3,600 Jobs
AstraZeneca Expands U.S. Manufacturing Footprint with $4.5 Billion Virginia Facility, Creating 3,600 Jobs and Advancing Domestic Biopharmaceutical Production AstraZeneca has announced an expanded commitment to U.S. manufacturing with a $4.5…
Laurus Labs Invests in Aarvik Therapeutics’ Series Seed 2 Funding Round
Aarvik Therapeutics Secures Strategic Investment from Laurus Labs in Series Seed 2 Financing Round Aarvik Therapeutics, a pioneering biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) for cancer therapy,…
Thermo Fisher Launches Molecular Microscope System for Lung Transplant Rejection Detection
Thermo Fisher Scientific Launches Molecular Microscope Diagnostic System to Transform Lung Transplant Rejection Detection and Management Thermo Fisher Scientific Inc., the global leader in serving science, has unveiled an innovative…
Charles River and Toxys Partner to Advance NAM-Based Developmental Toxicity Testing
Charles River and Toxys Partner to Advance NAM-Based Developmental Toxicity Testing Through ReproTracker® Collaboration Charles River Laboratories International, Inc. (NYSE: CRL) and Dutch biotechnology company Toxys have announced a strategic…
HealthTap Expands Diabetes Care Access via LillyDirect® Partnership
HealthTap Joins LillyDirect® to Expand Virtual Primary Care Access for Diabetes Management HealthTap, a leading provider of virtual primary care services in the United States, has announced that it will…
RIBOMIC Reports Positive Phase 2 Results for Umedaptanib in Achondroplasia
RIBOMIC’s Umedaptanib Pegol Achieves Strong Growth Outcomes in Children with Achondroplasia: Phase 2 Data Support Advancement to Late-Stage Clinical Development RIBOMIC, Inc. (TOKYO: 4591), a Japan-based clinical-stage biotechnology company focused…
Celltrion Shares Positive Real-World Data on IV-to-SC Infliximab Switch at UEG Week 2025
Celltrion Showcases Real-World Evidence Supporting Switch from IV to Subcutaneous Infliximab at UEG Week 2025 Celltrion, Inc., a global leader in biopharmaceutical innovation, today highlighted compelling real-world evidence supporting the…
Merz Therapeutics Strengthens European Footprint with New Polish Affiliate
Merz Therapeutics Strengthens European Footprint with Launch of New Affiliate in Poland Merz Therapeutics GmbH, a globally recognized leader in neurology-focused specialty pharmaceuticals, has officially announced the opening of its…
Aphios Wins NIH Grant to Advance Zindol® for Cancer-Related Nausea
Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer-Related Nausea and Vomiting Aphios Corporation, a pioneer in the development of advanced botanical pharmaceuticals and nutraceuticals, has received…
bioAffinity Technologies Achieves Record Third-Quarter 2025 Growth in CyPath® Lung Test Volume
bioAffinity Technologies Reports Record Third-Quarter 2025 Growth in CyPath® Lung Test Adoption, Driven by Expanding Clinical Use and Physician Confidence bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company pioneering…
Kairos Pharma Reports Positive Phase 2 Prostate Cancer Data at ESMO 2025
Kairos Pharma to Present Promising Phase 2 Prostate Cancer Data Highlighting Carotuximab’s Potential to Overcome Hormone Therapy Resistance at ESMO 2025 Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical…
Allurion Study Shows Over 20% Weight Loss With Consecutive Smart Capsule Use
Allurion Publishes Landmark Peer-Reviewed Study Demonstrating Over 20% Total Body Weight Loss With Consecutive Use of Its Smart Capsule Allurion Technologies, Inc. (NYSE: ALUR), a global leader in developing innovative,…